Cargando…

Terrific cells for SARS-CoV-2

Detalles Bibliográficos
Autor principal: Gottschalk, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316267/
https://www.ncbi.nlm.nih.gov/pubmed/36475524
http://dx.doi.org/10.3324/haematol.2022.282273
_version_ 1785067676906815488
author Gottschalk, Stephen
author_facet Gottschalk, Stephen
author_sort Gottschalk, Stephen
collection PubMed
description
format Online
Article
Text
id pubmed-10316267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-103162672023-07-04 Terrific cells for SARS-CoV-2 Gottschalk, Stephen Haematologica Editorial Fondazione Ferrata Storti 2022-12-07 /pmc/articles/PMC10316267/ /pubmed/36475524 http://dx.doi.org/10.3324/haematol.2022.282273 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Editorial
Gottschalk, Stephen
Terrific cells for SARS-CoV-2
title Terrific cells for SARS-CoV-2
title_full Terrific cells for SARS-CoV-2
title_fullStr Terrific cells for SARS-CoV-2
title_full_unstemmed Terrific cells for SARS-CoV-2
title_short Terrific cells for SARS-CoV-2
title_sort terrific cells for sars-cov-2
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316267/
https://www.ncbi.nlm.nih.gov/pubmed/36475524
http://dx.doi.org/10.3324/haematol.2022.282273
work_keys_str_mv AT gottschalkstephen terrificcellsforsarscov2